Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial. Pun, Patrick H.; Abdalla, Safa; Block, Geoffrey A.; Chertow, Glenn M.; Correa-Rotter, Ricardo; Dehmel, Bastian; Drüeke, Tilman B.; Floege, Jürgen; Goodman, William G.; Herzog, Charles A.; London, Gerard M.; Mahaffey, Kenneth W.; Moe, Sharon M.; Parfrey, Patrick S.; Wheeler, David C.; Middleton, John P.. Hemodialysis International. International Symposium on Home Hemodialysis. 2015; : . doi:10.1111/hdi.12382Article
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al. de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J.. Ann Oncol. 2015; 2196-7: p.2196-7. doi:10.1093/annonc/mdv301 10.1093/annonc/mdv301. Epub 2015 Jul 20.Article
High cardiovascular event rates occur within the first weeks of starting hemodialysis. Eckardt, Kai-Uwe; Gillespie, Iain A.; Kronenberg, Florian; Richards, Sharon; Stenvinkel, Peter; Anker, Stefan D.; Wheeler, David C.; de Francisco, Angel L.; Marcelli, Daniele; Froissart, Marc; Floege, Jürgen; ARO Steering Committee. Kidney International. 2015; : . doi:10.1038/ki.2015.117Article
Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review. Mamelle, E.; Borget, I.; Leboulleux, S.; Mirghani, H.; Suárez, C.; Pellitteri, P. K.; Shaha, A. R.; Hamoir, M.; Robbins, K. T.; Khafif, A.; Rodrigo, J. P.; Silver, C. E.; Rinaldo, A.; Ferlito, A.; Hartl, D. M.. Eur Arch Otorhinolaryngol. 2015; 1577-86: p.1577-86Article
Neurological complications in chronic kidney disease patients. Chillon, Jean-Marc; Massy, Ziad A.; Stengel, Bénédicte. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association. 2015; : . doi:10.1093/ndt/gfv315Article
[Post-partum: Guidelines for clinical practice--Short text]. Senat, M. V.; Sentilhes, L.; Battut, A.; Benhamou, D.; Bydlowski, S.; Chantry, A.; Deffieux, X.; Diers, F.; Doret, M.; Ducroux-Schouwey, C.; Fuchs, F.; Gascoin, G.; Lebot, C.; Marcellin, L.; Plu-Bureau, G.; Raccah-Tebeka, B.; Simon, E.; Breart, G.; Marpeau, L.. J Gynecol Obstet Biol Reprod (Paris). 2015; 44: p.1157-66. doi:10.1016/j.jgyn.2015.09.017Article
Is copeptin level associated with 1-year mortality after out-of-hospital cardiac arrest? Insights from the Paris registry*. Geri, Guillaume; Dumas, Florence; Chenevier-Gobeaux, Camille; Bouglé, Adrien; Daviaud, Fabrice; Morichau-Beauchant, Tristan; Jouven, Xavier; Mira, Jean-Paul; Pène, Frédéric; Empana, Jean-Philippe; Cariou, Alain. Critical Care Medicine. 2015; 43: p.422-429. doi:10.1097/CCM.0000000000000716Article
[Surveillance and detection of unusual events in toxicovigilance: Review of relevant methods]. Faisandier, L.; Fouillet, A.; Bicout, D. J.; Golliot, F.; Ahmed, I.; Bringay, S.; Eilstein, D.. Revue D'epidemiologie Et De Sante Publique. 2015; 63: p.119-131. doi:10.1016/j.respe.2015.01.072Article
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma. Hadoux, J.; Malka, D.; Planchard, D.; Scoazec, J. Y.; Caramella, C.; Guigay, J.; Boige, V.; Leboulleux, S.; Burtin, P.; Berdelou, A.; Loriot, Y.; Duvillard, P.; Chougnet, C. N.; Déandréis, D.; Schlumberger, M.; Borget, I.; Ducreux, M.; Baudin, E.. Endocr. Relat. Cancer. 2015; 289-98: p.289-98Article
Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome. Patrikidou, A.; Brureau, L.; Casenave, J.; Albiges, L.; Di Palma, M.; Patard, J. J.; Baumert, H.; Blanchard, P.; Bossi, A.; Kitikidou, K.; Massard, C.; Fizazi, K.; Blanchet, P.; Loriot, Y.. Urol Oncol. 2015; 202-e9-17: p.202-e9-17. doi:10.1016/j.urolonc.2015.01.022 10.1016/j.urolonc.2015.01.022. Epub 2015 Mar 5.Article